Abstract
Hypofractionated radiotherapy approaches varying from single-fraction radiosurgery to 15-fraction short-course radiotherapy have been used with increasing frequency for managing a wide spectrum of benign and malignant primary tumors of the brain and skull base. Tumor control rates and complication rates appear comparable to those for fractionated conventional radiotherapy in most reports.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brada M, Burchell L, Ashley S et al (1999) The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 45(3):693–698
Breen P, Flickinger JC, Kondziolka D et al (1998) Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 89(6):933–938
Chun SG, Nedzi LA, Choe KS et al (2014) A retrospective analysis of tumor volumetric responses to five-fraction stereotactic radiotherapy for paragangliomas of the head and neck (glomus tumors). Stereotact Funct Neurosurg 92(3):153–159
Douglas BG, Fowler JF (1976) The effect of multiple small doses of X-rays on skin reactions in the mouse and a basic interpretation. Radiat Res 66:401–426
Flickinger JC, Nelson PB, Taylor FH et al (1989) Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 63(12):2404–2408
Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D et al (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300(5622):1155–1159
Haghighi N, Seely A, Paul E et al (2015) Hypofractionated stereotactic radiotherapy for benign intracranial tumours of the cavernous sinus. J Clin Neurosci 22(9):1450–1455
Han J, Girvigian MR, Chen JC et al (2014) A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma. Am J Clin Oncol 37(3):255–260
Harris JR, Levene MB (1976) Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 120(1):167–171
Hashizume C, Mori Y, Kobayashi T et al (2010) Stereotactic radiotherapy using Novalis for craniopharyngioma adjacent to optic pathways. J Neuro-Oncol 98(2):239–247
Haviland JS, Owen JR, Dewar JA et al (2013) The UK Standardization of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomized controlled trials. Lancet Oncol 14(11):1086–1094
Henderson FC, McCool K, Seigle J et al (2009) Treatment of chordomas with CyberKnife: Georgetown university experience and treatment recommendations. Neurosurgery 64(2 Suppl):A44–A53
Iwata H, Tatewaki K, Inoue M et al (2012) Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma. J Neuro-Oncol 106(3):571–577
Iwata H, Sato K, Nomura R et al (2016) Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus. J Neuro-Oncol 128(2):267–275
Jiang B, Veeravagu A, Feroze AH et al (2013) CyberKnife radiosurgery for the management of skull base and spinal chondrosarcomas. J Neuro-Oncol 114(2):209–218
Kano H, Iqbal FO, Sheehan J et al (2011) Stereotactic radiosurgery for chordoma: a report from the North American Gamma Knife Consortium. Neurosurgery 68(2):379–389
Kano H, Sheehan J, Sneed PK et al (2015) Skull base chondrosarcoma radiosurgery: report of the North American Gamma Knife Consortium. J Neurosurg 123(5):1268–1275
Kobayashi T, Tsugawa T, Hatano M et al (2015) Gamma knife radiosurgery of craniopharyngioma: results of 30 cases treated at Nagoya Radiosurgery Center. Nagoya J Med Sci 77(3):447–454
Lee CC, Kano H, Yang HC et al (2014a) Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas. J Neurosurg 120(3):647–654
Lee CC, Yang HC, Chen CJ et al (2014b) Gamma knife surgery for craniopharyngioma: report on a 20-year experience. J Neurosurg 121(Suppl):167–178
Malmström A, Grønberg BH, Marosi C et al (2012 Sep) Nordic Clinical Brain Tumour Study Group (NCBTSG). Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomized, phase 3 trial. Lancet Oncol 13(9):916–926
Maranzano E, Draghini L, Casale M et al (2015 Dec) Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas. Strahlenther Onkol 191(12):953–960
Mousavi SH, Niranjan A, Akpinar B et al (2016) Hearing sub-classification may predict long-term auditory outcomes after radiosurgery for vestibular schwannoma patients with good hearing. J Neurosurg 125(4):845–852
Navarria P, Pessina F, Cozzi L et al (2015) Hypofractionated stereotactic radiation therapy in skull base meningiomas. J Neuro-Oncol 124(2):283–289
Niranjan A, Kano H, Mathieu D et al (2010) Radiosurgery for craniopharyngioma. Int J Radiat Oncol Biol Phys 78(1):64–71
Park C, Papiez L, Zhang S et al (2008) Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70(3):847–852
Park KJ, Kano H, Parry PV et al (2011) Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery 69(6):1188–1199
Perry JR, Laperriere N, O’Callaghan CJ et al (2016) A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677). J Clin Oncol 34 (suppl; abstr LBA2)
Phillips C, Guiney M, Smith J et al (2003) A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68(1):23–26
Roa W, Brasher PM, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22(9):1583–1588
Roa W, Kepka L, Kumar N et al (2015) International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 33(35):4145–4150
Schulz-Ertner D, Karger CP, Feuerhake A et al (2007) Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 68(2):449–457
Sheehan JP, Niranjan A, Sheehan JM et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102(4):678–691
Sheehan JP, Tanaka S, Link MJ et al (2012) Gamma Knife surgery for the management of glomus tumors: a multicenter study. J Neurosurg 117(2):246–254
Sheehan JP, Cohen-Inbar O, Ruangkanchanasetr R et al (2015) Post-radiosurgical edema associated with parasagittal and parafalcine meningiomas: a multicenter study. J Neuro-Oncol 125(2):317–324
Yovino S, Kleinberg L, Grossman SA et al (2013) The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Investig 31(2):140–144
Zaghloul MS, Eldebawy E, Ahmed S et al (2014) Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiother Oncol 111(1):35–40
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Flickinger, J.C. (2017). Altered Fractionation in Radiotherapy of CNS Tumors. In: Trombetta, M., Pignol, JP., Montemaggi, P., Brady, L.W. (eds) Alternate Fractionation in Radiotherapy. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2017_31
Download citation
DOI: https://doi.org/10.1007/174_2017_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51197-9
Online ISBN: 978-3-319-51198-6
eBook Packages: MedicineMedicine (R0)